Quit Smoking
Smokers age 18 or older are needed to participate in a clinical study to stop smoking. Volunteers who suffer from cancer, heart disease, lung disease, diabetes, high blood pressure or cholesterol, circulation problems, cataracts, acid reflux, ulcers, osteoporosis, abnormal Pap tests or erectile dysfunction may be eligible to participate in the study. All medications are FDA approved and will be provided at no cost.
Michael Steinberg, MD, MPH, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, is the principal investigator. For more
information call 732-235-7149.
Discuss Your Smoking
A study for smokers age 18 or older is being conducted at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. Volunteers must have one or more of the following conditions: cancer, heart disease, lung disease, diabetes, high blood pressure or cholesterol, circulation problems, cataracts, acid reflux, ulcers, osteoporosis, abnormal Pap tests or erectile dysfunction to participate in a study to discuss smoking. Volunteers do not need to want to quit smoking. Participants will be asked to meet for one hour and have a 20-minute telephone follow-up. Upon completion of the study, participants will receive a $25 gift card.
Michael Steinberg, MD, MPH, RWJMS, New Brunswick, is the principal investigator. For more information call 732-235-7149.
Diabetes Mellitus
Volunteers between the ages of 18 and 70 with diabetes mellitus, who are experiencing numbness, tingling or burning in the hands and/or feet, may qualify to participate in a study for an investigational medication for diabetic peripheral neuropathy. If eligible, participants will receive relevant laboratory tests, a physical exam and study tablets at no cost.
Stephen H. Schneider, MD, in the Department of Medicine at UMDNJ-Robert Wood Johnson Medical School, New Brunswick, is the principal investigator. For more information call
732-235-7751.
Oral Contraceptive
The Women’s Health Institute at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is conducting a research study to test an extended cycle low-dose oral contraceptive.
Women in good health between the ages of 18 and 40 are being sought to participate. They must be sexually active and in a stable relationship. A physical exam, and Pap, blood and pregnancy tests will be provided at no cost. The
one-year study requires six visits and participants will be compensated $25/visit for
travel expenses.
Gloria A. Bachmann, MD, is the principal investigator. For additional information contact study coordinator Fran Christ, RN, APN-C, at 732-235-8664 or email christmf@umdnj.edu, Monday through Friday, between 9 am and 4 pm. All calls are confidential.
Overactive Bladder
Sexually active heterosexual women age 18 and older are needed for a 24-week overactive bladder and urinary urge incontinence study at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. To be eligible to participate,
volunteers must have at least one or more episodes of urinary urge incontinence and urinate at least eight or more times in 24 hours. Participants will receive a physical examination and blood studies at no cost, and will be required to make five office visits.
The principal investigator is Gloria A. Bachmann, MD, Women’s Health Institute. For more information contact the study coordinator Diane Dawicki at 732-235-7353 or call the Women’s Health Institute at 732-235-8664. All calls are confidential.
Vulvodynia Study
The Women’s Health Institute at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is recruiting female volunteers between the ages of 18 and 80 who are experiencing chronic pain in the vaginal area, including burning, stinging, and/or tenderness that have lasted for at least six months, to participate in a four-month study. In addition, participants must not be currently involved in any other research study. Those who qualify will receive dietary counseling and physical exams at no cost. Upon completion of the study, monetary compensation of $90 will be provided.
Gloria Bachmann, MD, is the principal investigator. For additional information call 732-235-7799 or 732-235-7965, Monday through Friday, between 9 AM and 4 PM.
Parkinson’s Disease
A study of depression in patients with Parkinson’s disease (PD), using medications approved for depression, is being conducted at UMDNJ-Robert Wood Johnson Medical School in Piscataway. The study is funded by the National Institutes of Health. To be eligible, participants must have PD and be experiencing the following:
• getting more and more isolated;
• feeling sad or empty most of the day;
• difficulty falling asleep or staying asleep;
• loss of interest in daily activities;
• inability to concentrate.
An extensive psychiatric evaluation is provided at no cost. Participants will be
compensated $30 for each study visit.
Matthew Menza, MD, is the principal investigator. For further details call Allison Dicke, toll free, at
1-877-795-4673.
Generalized Anxiety
UMDNJ-Robert Wood Johnson Medical School in Piscataway is conducting a study of investigational medications for treatment-resistant generalized anxiety disorder (GAD). To be eligible to participate, volunteers must suffer from excessive worry, nervousness, restlessness, irritability, sleeping problems and an inability to concentrate. All research care including an extensive psychiatric evaluation is provided at no cost. Participants will be paid $30 for each study visit.
Matthew Menza, MD, is the principal investigator. For additional information call Regine Rousso, toll free, at 1-877-RWJ-HOPE (1-877-795-4673).
Type II Diabetes
The National Institutes of Health is doing a research study to find ways to reduce the risk of heart attack, stroke and other serious blood vessel problems for individuals who have Type II diabetes.
To be eligible to participate in the Action to Control Cardiovascular Risk in Diabetes study (ACCORD), participants must have Type II diabetes and meet one of the following criteria:
• age 55 or older;
• age 40 or older with previous heart attack, stroke or serious blood vessel problems.
Those who qualify will receive blood sugar and blood pressure or cholesterol medications, blood sugar testing supplies, regular medical follow-up, and counseling and education for healthy lifestyle choices.
Arnaud Bastien, MD, Department of Medicine at UMDNJ-Robert Wood Johnson Medical School, Camden, is the principal investigator. For more information call Cooper University Hospital at 856-968-7695.
Schizophrenia
The Division of Child and Adolescent Psychiatry at UMDNJ-Robert Wood Johnson Medical School in Piscataway is doing a medical research study to evaluate the safety and effectiveness of an atypical antipsychotic medication for adolescents who have symptoms of schizophrenia. To participate, volunteers must be between the ages of 13 and 17, and be experiencing any of the following symptoms:
• disorganized speech that is incoherent at times;
• seeing things that are not there;
• often appearing distracted;
• appearing to hear voices when no one is there;
• an inability to focus on tasks;
• disorganized thoughts and behaviors;
• social withdrawal
• feeling like people are out to get them.
Health insurance is not needed to be eligible for participation.
Qualified participants will receive study related medication and study related evaluation funded by a major pharmaceutical company.
The principal investigator is Theodore Petti, MD. For more information contact Kurt Bopp, clinical research coordinator, at 732-235-5690.
Childhood Autism
Volunteers between the ages of 5 and 17 are needed to participate in a 12-week clinical drug study on autism in the Division of Child and Adolescent Psychiatry at UMDNJ-Robert Wood Johnson Medical School in Piscataway. The purpose of the study is to explore treatment options for children with autism. To be eligible, participants must have a diagnosis of autism and they must be willing to undergo an interview. The interview and questionnaires may take four hours to complete. The interview can be completed at the second visit if necessary. Medication will be provided at no cost. Those who qualify will be closely monitored by the study doctor.
Sherie Novotny, MD, is the principal investigator. For more information call Kurt Bopp, clinical research coordinator, at 732-235-5690.
Gastrointestinal Problems in Autistic Children
A research study is being conducted at UMDNJ-Robert Wood Johnson Medical School in Piscataway to evaluate an investigational medication for gastrointestinal problems in autistic children. Fifty percent of children with autistic disorder experience regular gastrointestinal problems such as chronic diarrhea or
constipation, bloating, gas and abdominal pain. Although these symptoms are common and can significantly impact the quality of life of autistic children and their families, very little is known about their cause or appropriate treatments. To be eligible, participants must be between the ages of 2 and 17 and experience some of the above symptoms. Participants will be provided study medication and medical care at no cost.
Sherie Novotny, MD, is the principal investigator. For more details contact the
clinical research coordinator Kurt Bopp at 732-235-5690.
Schizophrenia and Anxiety
Participants are needed for a 16-week clinical drug study on
schizophrenia and anxiety at UMDNJ-University Behavioral HealthCare,Extended Treatment, in New Brunswick. The purpose of the study is to explore treatment options for individuals with schizophrenia and social anxiety symptoms. To be eligible, volunteers must be between the ages of 18 and 65, must have a diagnosis of schizophrenia or schizoaffective disorder, and be willing to undergo an interview. Those who qualify may receive up to $280 for participation and an additional $20 for each visit, if travel is involved.
Theodore Petti, MD, MPH, is the principal investigator. Contact Kurt Bopp,
clinical research coordinator, for more information about the study at 732-235-5690.
Bipolar Disorder
Aresearch study of an investigational medication for children and adolescents between the ages of 10 and 17 is being conducted in the Division of Child Adolescent Psychiatry at UMDNJ-Robert Wood Medical School in Piscataway. To be eligible to participate, volunteers must have been diagnosed with bipolar disorder (manic depressive illness). In addition, they have experienced some or all of the following symptoms:
• extreme shifts in energy, mood, or behavior (mood swings);
• difficulty functioning in school, with friends or at home;
• sleep changes;
• impulsivity;
• excessive irritability;
• inability or reduced ability to concentrate.
Participants will receive medical and psychological evaluations, treatment, investigational medication and close medical supervision at no cost. Theodore Petti, MD, MPH, is the principal investigator. For more information contact Kurt Bopp at
732-235-5690.
Cholesterol
The Preventive Cardiology Program at UMDNJ-New Jersey Medical School is conducting a research trial called JUPITER. The goal of the study is to evaluate whether a recently approved cholesterol lowering statin medication will reduce the risk of heart attack or stroke in individuals with normal levels of cholesterol, but with high levels of C-Reactive Protein (CRP), a measure of inflammation. Qualifications for study participation include:
• men must be age 55 or older;
• women must be age 65 or older;
• no prior history of heart attack, stroke, diabetes or chronic arthritis;
• must not be taking hormone replacement therapy or any medications to lower cholesterol.
Participants will receive study-related medical exams, blood work (including CRP) and study medication. All study visits will be conducted at the Doctors Office Center (DOC), 90 Bergen Street, Suite 4200 in Newark.
Norman L. Lasser, MD, PhD, FAHA, director of the Preventive Cardiology Program, is the principal investigator. Call Roberta Silverberg at 973-972-6107 for additional information.
Acupuncture
Healthy volunteers are needed for an acupuncture study at UMDNJ-New Jersey Medical School. The goal of the study is to examine brain responses during acupuncture stimulation using functional MRI. Participants must be between the ages of 18 and 70 (female volunteers must not be pregnant). The study requires four one-hour sessions. Those who qualify will receive a copy of their MRI brain images at no cost.
Susan C. Feldman, PhD, Department of Radiology, is the principal investigator. For more information contact Drs. Wen-Ching Liu or Susan Feldman at 973-972-4797 (sufeldma@umdnj.edu).
Colorectal Cancer
Healthy volunteers at risk for colorectal cancer are needed for a clinical trial at The Cancer Institute of New Jersey in New Brunswick. The trial is looking to see if an aspirin-like drug or a substance found in curry and mustard can prevent the development of colorectal polyps.
A colorectal screening colonoscopy is provided to volunteers at Robert Wood Johnson University Hospital in New Brunswick as part of this investigation. Compensation is offered to offset the costs of participation.
Steven J. Shiff, MD, is the principal investigator. For more information contact The Cancer Institute of New Jersey at 1-866-654-9898 and select option #1.
Endometrial (Uterine) Cancer
The Cancer Institute of New Jersey (CINJ) in New Brunswick is testing whether a medicated intrauterine device can prevent endometrial cancer and precancer. MIRENA® is an intrauterine system that contains the medication levonorgestrel. It is usually used to prevent pregnancy and has been utilized for more than 12 years in Europe with minimal side effects. MIRENA® has demonstrated some efficacy in small studies. Potential participants must: be willing to have MIRENA® inserted and keep a record of vaginal bleeding; be between the ages of 40 and 50; and be obese. Women who are heavy are at increased risk of endometrial cancer. Participants will receive pelvic exams and endometrial biopsies at no cost. In addition, they will be seen at CINJ approximately seven times during the study.
Allison Wagreich, MD, is the principal investigator. For more information call CINJ at 1-866-654-9898.
